About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
BOARD MEETINGS
Board
Meetings
Sampre Nutritions Ltd.
From Date
:
To Date
:
Source Date
Board Meeting Date
Details
30-Sep-2025
03-Oct-2025
Inter alia to transact the following items:- 1. To offer, issue and allot securities by way of preferential allotment. 2. To approve issuance of foreign currency convertible bonds (FCCBs).
15-Sep-2025
19-Sep-2025
Stock Split & Bonus issue
25-Aug-2025
25-Aug-2025
A.G.M.
15-Jul-2025
18-Jul-2025
Quarterly Results
30-May-2025
04-Jun-2025
Audited Results
22-May-2025
30-May-2025
Audited Results(Cancelled) (Cancelled)
21-Feb-2025
28-Feb-2025
Cancelled Board Meeting (Cancelled)
10-Feb-2025
13-Feb-2025
Quarterly Results & Preferential Issue of shares
11-Nov-2024
14-Nov-2024
Quarterly Results & Preferential Issue of shares
06-Aug-2024
13-Aug-2024
Quarterly Results
25-Jun-2024
28-Jun-2024
Inter alia, to consider and approve:- (1) Issuance of Foreign Currency Convertible Bonds (FCCB''s) Further Company has entered into Subscription Agreement with the Lead Arranger - Aries Capital Limited, an Investment Manager company appointed for the purpose of the FCCB issue.
22-May-2024
30-May-2024
Audited Results
05-Feb-2024
12-Feb-2024
Quarterly Results
06-Nov-2023
14-Nov-2023
Quarterly Results & Preferential Issue of shares
07-Aug-2023
14-Aug-2023
Quarterly Results
23-May-2023
30-May-2023
Audited Results
02-Feb-2023
09-Feb-2023
Quarterly Results
07-Nov-2022
12-Nov-2022
Quarterly Results
03-Oct-2022
07-Oct-2022
Inter alia, to consider and approve and decide upon alternatives to increase the production capacities by way of identifying and acquiring running plant with production capacities meeting quantity and quality requirements of the company or though greenfield investment options.
16-Sep-2022
20-Sep-2022
Inter alia, to consider and approve further raising of FCCB upto 100 million $ in one or more tranches to finance the capital and working capital for overseas expansion by way of preferential allotment.
Page
1
of
4
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.